Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 10,000 shares at $72.68 ($727K) on 2023-10-10, disclosed to the SEC on 2023-10-10.
Scheduled sale ($727k) by CVP, Critical Care under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.68 | 5,000 | $363K | 50.0% |
| 2 | $72.68 | 5,000 | $363K | 50.0% |
| Total | $72.68 avg | 10,000 | $727K | 100% |
| Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |
| EW | SELL | 2023-06-13 | $429K | — | Filing → |